2012
DOI: 10.1016/j.mam.2012.03.005
|View full text |Cite
|
Sign up to set email alerts
|

Nutritional modulation of age-related macular degeneration

Abstract: Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly worldwide. It affects 30–50 million individuals and clinical hallmarks of AMD are observed in at least one third of persons over the age of 75 in industrialized countries (Gehrs et al., 2006). Costs associated with AMD are in excess of $340 billion US (American-Health-Assistance-Foundation, 2012). The majority of AMD patients in the United States are not eligible for clinical treatments (Biarnes et al., 2011; Klein et al., … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
56
0
2

Year Published

2014
2014
2018
2018

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 76 publications
(58 citation statements)
references
References 174 publications
0
56
0
2
Order By: Relevance
“…Similarly, a significant synergistic interaction was described with regard to omega-3 fatty acids and dietary glycemic index; higher intake of omega-3 fatty acids (DHA and EPA) and low dietary glycemic index were associated with an even lower risk for advanced AMD compared to either of the two dietary factors alone [78]. In addition, recent studies on murine models also support these results [22,88].…”
Section: Dietary Carbohydratesmentioning
confidence: 76%
See 4 more Smart Citations
“…Similarly, a significant synergistic interaction was described with regard to omega-3 fatty acids and dietary glycemic index; higher intake of omega-3 fatty acids (DHA and EPA) and low dietary glycemic index were associated with an even lower risk for advanced AMD compared to either of the two dietary factors alone [78]. In addition, recent studies on murine models also support these results [22,88].…”
Section: Dietary Carbohydratesmentioning
confidence: 76%
“…However, current knowledge does not support the clinical use of supplements in patients with AMD. Several reviews have analyzed data obtained from case-controlled studies and randomized trials and have also found no evidence of supplements benefiting healthy people [22,35]. Evans and Lawrenson emphasized the clinical practice implications by stating: "there is no evidence from randomized controlled trials that healthy people should take antioxidant vitamin and mineral supplements to prevent or delay the onset of AMD."…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations